How I treat the young patient with multiple myeloma.

Abstract:

:The treatment landscape for multiple myeloma has been transformed by the introduction of novel agents, including immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies. These have been shown to be more effective and generally better tolerated than conventional chemotherapy, with their introduction into clinical practice leading to improved survival. Furthermore, a better understanding of disease biology, improved diagnostic criteria, and the development of sensitive and specific tools for disease prognostication have contributed to better outcome. Treatment in the younger patient can now be individualized based on host and disease features with enhanced monitoring of response and use of high-sensitivity techniques for evaluating residual disease. The current standard of care has been significantly enhanced by novel agents with a paradigm shift toward optional or delayed autologous stem cell transplant as a reasonable choice in selected patients. Conversely, extended treatment with induction of remission followed by maintenance strategies is now a standard of care, conferring prolonged disease control with more manageable toxicities in both the short and long term, as well as improved quality of life.

journal_name

Blood

journal_title

Blood

authors

Gandolfi S,Prada CP,Richardson PG

doi

10.1182/blood-2017-05-693606

subject

Has Abstract

pub_date

2018-09-13 00:00:00

pages

1114-1124

issue

11

eissn

0006-4971

issn

1528-0020

pii

blood-2017-05-693606

journal_volume

132

pub_type

杂志文章,评审

相关文献

BLOOD文献大全
  • The evolving contribution of hematopoietic progenitor cells to lymphomagenesis.

    abstract::Recent genomic studies have outlined a landscape of recurrent alterations within some subtypes of lymphoid cancer. Yet, the timing and cellular contexts during which these alterations occur (ie, the molecular ontogeny) remain poorly understood. Lymphoid malignancies offer an exceptional opportunity to delineate the on...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2012-05-414995

    authors: Weigert O,Weinstock DM

    更新日期:2012-09-27 00:00:00

  • The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12.

    abstract::The splenic marginal zone (MZ) is comprised of specialized populations of B cells, dendritic cells, and macrophages that are uniquely arrayed outside the white pulp follicles to screen the blood for bacterial and other particulate Ags. Mechanisms responsible for MZ B-cell formation, localization, retention, and functi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-343608

    authors: Wang H,Beaty N,Chen S,Qi CF,Masiuk M,Shin DM,Morse HC 3rd

    更新日期:2012-01-12 00:00:00

  • Transplant strategies in relapsed/refractory Hodgkin lymphoma.

    abstract::The majority of patients with Hodgkin lymphoma (HL) are cured with initial therapy. However, high-dose therapy with autologous hematopoietic cell transplant (AHCT) allows for the cure of an additional portion of patients with relapsed or primary refractory disease. Positron emission tomography-negative complete remiss...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-09-772673

    authors: Shah GL,Moskowitz CH

    更新日期:2018-04-12 00:00:00

  • Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptor.

    abstract::Adoptive transfer of patient-derived T cells modified to express chimeric antigen receptors (CARTs) has demonstrated dramatic success in relapsed/refractory pre-B-cell acute lymphoblastic leukemia (ALL), but response and durability of remission requires exponential CART expansion and persistence. Tumors are known to a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-12-815548

    authors: Qin H,Ishii K,Nguyen S,Su PP,Burk CR,Kim BH,Duncan BB,Tarun S,Shah NN,Kohler ME,Fry TJ

    更新日期:2018-11-01 00:00:00

  • Intersubunit circular permutation of human hemoglobin.

    abstract::For many years, human hemoglobin (Hb) isolated from erythrocytes has been investigated as a potential oxygen delivery therapeutic. Advantages with respect to the need for blood typing were balanced with various undesirable properties of cell-free Hb, including cost, overall oxygen affinity, alterations in cooperativit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v100.1.299

    authors: Sanders KE,Lo J,Sligar SG

    更新日期:2002-07-01 00:00:00

  • Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses.

    abstract::The tyrosine kinase inhibitors sorafenib and sunitinib are approved for the treatment of patients with malignant diseases. To analyze the possible use of these compounds in combination with immunotherapeutic approaches, we analyzed the effects of both inhibitors on the immunostimulatory capacity of human dendritic cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-02-075945

    authors: Hipp MM,Hilf N,Walter S,Werth D,Brauer KM,Radsak MP,Weinschenk T,Singh-Jasuja H,Brossart P

    更新日期:2008-06-15 00:00:00

  • Transient response to imatinib mesylate (STI571) in a patient with the ETV6-ABL t(9;12) translocation.

    abstract::We report the transient response of a patient with the ETV6-ABL fusion gene to imatinib mesylate (STI571). A 38-year-old man was referred with an erroneous diagnosis of Philadelphia-positive chronic myeloid leukemia in blastic transformation for treatment with the ABL tyrosine kinase inhibitor, STI571. Further investi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.9.3465

    authors: O'Brien SG,Vieira SA,Connors S,Bown N,Chang J,Capdeville R,Melo JV

    更新日期:2002-05-01 00:00:00

  • A point mutation in the bulge of the iron-responsive element of the L ferritin gene in two families with the hereditary hyperferritinemia-cataract syndrome.

    abstract::The molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome is the presence of a mutation in the iron-responsive element (IRE) of the L ferritin gene, located on chromosome 19q13.3-13.4. Two mutations have been reported so far, altering adjacent nucleotides in the IRE loop, in a regio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Martin ME,Fargion S,Brissot P,Pellat B,Beaumont C

    更新日期:1998-01-01 00:00:00

  • Effect of age on hematopoiesis in man.

    abstract::We have shown previously that the cause of anemia in healthy elderly subjects can usually not be identified. In this study, hematopoiesis was examined in 18 healthy elderly subjects with unexplained anemia and in 15 young and 15 healthy elderly individuals without anemia. No reduction in circulating testosterone was n...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lipschitz DA,Udupa KB,Milton KY,Thompson CO

    更新日期:1984-03-01 00:00:00

  • Prediction of response to chemotherapy in acute myelocytic leukemia.

    abstract::Marrow specimens obtained from 23 patients with acute myelocytic leukemia were exposed to cytosine arabinoside and/or daunorubicin in vitro, and the effects of these agents on colony formation in vitro was determined. Thymidine suicide indices were determined as well, which permitted a distinction to be made between k...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Preisler HD

    更新日期:1980-09-01 00:00:00

  • A genome-wide association analysis of serum iron concentrations.

    abstract::To investigate genetic variants that affect iron concentrations in persons not affected by overt genetic disorders of iron metabolism, a genome-wide association study was conducted in the InCHIANTI Study (N = 1206) and the Baltimore Longitudinal Study of Aging (N = 713). The top 2 single-nucleotide polymorphisms were ...

    journal_title:Blood

    pub_type: 杂志文章,meta分析

    doi:10.1182/blood-2009-07-232496

    authors: Tanaka T,Roy CN,Yao W,Matteini A,Semba RD,Arking D,Walston JD,Fried LP,Singleton A,Guralnik J,Abecasis GR,Bandinelli S,Longo DL,Ferrucci L

    更新日期:2010-01-07 00:00:00

  • Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation.

    abstract::The number of cells transplanted and their capacity to induce graft-versus-host reactivity (GvHR) are two factors that are suspected to influence the engraftment of allogeneic bone marrow. We have investigated their impact on graft rejection rates in busulfan-treated LEW rats. In a series of experiments, we varied (1)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Uharek L,Gassmann W,Glass B,Steinmann J,Loeffler H,Mueller-Ruchholtz W

    更新日期:1992-03-15 00:00:00

  • Platelet-associated complement factor H in healthy persons and patients with atypical HUS.

    abstract::Atypical hemolytic uremic syndrome (aHUS) is associated with complement system dysregulation, and more than 25% of pediatric aHUS cases are linked to mutations in complement factor H (CFH) or CFH autoantibodies. The observation of thrombocytopenia and platelet-rich thrombi in the glomerular microvasculature indicates ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-205096

    authors: Licht C,Pluthero FG,Li L,Christensen H,Habbig S,Hoppe B,Geary DF,Zipfel PF,Kahr WH

    更新日期:2009-11-12 00:00:00

  • Ex vivo characterization and isolation of rare memory B cells with antigen tetramers.

    abstract::Studying human antigen-specific memory B cells has been challenging because of low frequencies in peripheral blood, slow proliferation, and lack of antibody secretion. Therefore, most studies have relied on conversion of memory B cells into antibody-secreting cells by in vitro culture. To facilitate direct ex vivo iso...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-341917

    authors: Franz B,May KF Jr,Dranoff G,Wucherpfennig K

    更新日期:2011-07-14 00:00:00

  • Neutralization of tumor necrosis factor activity shortly after the onset of dendritic cell hematopoiesis reveals a novel mechanism for the selective expansion of the CD14-dependent dendritic cell pathway.

    abstract::The CD14-dependent and -independent dendritic cell (DC) pathways are instituted simultaneously when CD34(+) progenitor cells are treated with granulocyte-macrophage colony-stimulating factor (GM-CSF)/tumor necrosis factor (TNF) +/- stem cell factor (SCF) (GTS). If TNF activity is neutralized within 48 hours of cytokin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Santiago-Schwarz F,McCarthy M,Tucci J,Carsons SE

    更新日期:1998-08-01 00:00:00

  • The distal cytoplasmic domain of the erythropoietin receptor induces granulocytic differentiation in 32D cells.

    abstract::The role of hematopoietic growth factors in lineage commitment and differentiation is unclear. We present evidence that heterologous expression of an erythroid specific receptor allows granulocytic differentiation of a myeloid cell line. We have previously characterized a truncation mutant of the erythropoietin recept...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Harris KW,Hu XJ,Schultz S,Arcasoy MO,Forget BG,Clare N

    更新日期:1998-08-15 00:00:00

  • Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity.

    abstract::Activation of inflammatory and procoagulant mechanisms is thought to contribute significantly to the initiation of restenosis, a common complication after balloon angioplasty of obstructed arteries. During this process, expression of tissue factor (TF) represents one of the major physiologic triggers of coagulation th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-04-1148

    authors: Kopp CW,Hölzenbein T,Steiner S,Marculescu R,Bergmeister H,Seidinger D,Mosberger I,Kaun C,Cejna M,Horvat R,Wojta J,Maurer G,Binder BR,Breuss JM,Ecker RC,de Martin R,Minar E

    更新日期:2004-03-01 00:00:00

  • RANK ligand and osteoprotegerin in myeloma bone disease.

    abstract::Myeloma bone disease is due to interactions of myeloma cells with the bone marrow microenvironment, and is associated with pathologic fractures, neurologic symptoms and hypercalcemia. Adjacent to myeloma cells, the formation and activation of osteoclasts is increased, which results in enhanced bone resorption. The rec...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2002-09-2684

    authors: Sezer O,Heider U,Zavrski I,Kühne CA,Hofbauer LC

    更新日期:2003-03-15 00:00:00

  • Human platelet cGI-PDE: expression in yeast and localization of the catalytic domain by deletion mutagenesis.

    abstract::Cyclic adenosine monophosphate (cAMP) is an important modulator of platelet responses to agonists. Cyclic nucleotide phosphodiesterase (PDE) controls intracellular cAMP concentrations by hydrolyzing it to AMP. The major PDE activity in platelets is PDE3A (cyclic guanosine monophosphate [cGMP]-inhibited PDE). To obtain...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cheung PP,Xu H,McLaughlin MM,Ghazaleh FA,Livi GP,Colman RW

    更新日期:1996-08-15 00:00:00

  • The clinical applications of genome editing in HIV.

    abstract::HIV/AIDS has long been at the forefront of the development of gene- and cell-based therapies. Although conventional gene therapy approaches typically involve the addition of anti-HIV genes to cells using semirandomly integrating viral vectors, newer genome editing technologies based on engineered nucleases are now all...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-01-678144

    authors: Wang CX,Cannon PM

    更新日期:2016-05-26 00:00:00

  • Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.

    abstract::Wiskott-Aldrich syndrome (WAS) is a rare X-linked immunodeficiency with microthrombocytopenia, eczema, recurrent infections, autoimmune disorders, and malignancies that are life-threatening in the majority of patients. In this long-term, retrospective, multicenter study, we analyzed events that occurred in 96 WAS pati...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2007-03-076679

    authors: Ozsahin H,Cavazzana-Calvo M,Notarangelo LD,Schulz A,Thrasher AJ,Mazzolari E,Slatter MA,Le Deist F,Blanche S,Veys P,Fasth A,Bredius R,Sedlacek P,Wulffraat N,Ortega J,Heilmann C,O'Meara A,Wachowiak J,Kalwak K,Matthes-

    更新日期:2008-01-01 00:00:00

  • Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota.

    abstract::Bone marrow suppression is an adverse effect associated with many antibiotics, especially when administered for prolonged treatment courses. Recent advances in our understanding of steady-state hematopoiesis have allowed us to explore the effects of antibiotics on hematopoietic progenitors in detail using a murine mod...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-03-708594

    authors: Josefsdottir KS,Baldridge MT,Kadmon CS,King KY

    更新日期:2017-02-09 00:00:00

  • Alloantigenic composition of the endothelial vitronectin receptor.

    abstract::Endothelial cells synthesize a heterodimeric adhesion molecule, the vitronectin receptor (VnR), which is similar to the platelet glycoprotein (GP)IIb/IIIa complex. The subunits of the endothelial VnR (VnR alpha and GPIIIa) have been studied for their ability to express alloantigens associated with platelet GPIIb and I...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Giltay JC,Leeksma OC,von dem Borne AE,van Mourik JA

    更新日期:1988-07-01 00:00:00

  • Normal human serum contains natural antibodies reactive with autologous ABO blood group antigens.

    abstract::It is widely accepted that the serum of healthy individuals contains natural antibodies only against those blood group A or B antigens that are not expressed on the individual's red blood cells. The mechanisms involved in tolerance to autologous blood group antigens remain unclear. In the present study, we show that I...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Spalter SH,Kaveri SV,Bonnin E,Mani JC,Cartron JP,Kazatchkine MD

    更新日期:1999-06-15 00:00:00

  • Cell surface expression of c-kit receptors by childhood acute myeloid leukemia blasts is not of prognostic value: a report from the Childrens Cancer Group.

    abstract::The prognostic significance of c-kit receptor expression on leukemic blast cells was determined in 122 children with acute myeloid leukemia (AML) entered onto Childrens Cancer Group protocol 213. Clinical and laboratory characteristics as well as outcome were analyzed according to the percentage of blast cells express...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Smith FO,Broudy VC,Zsebo KM,Lampkin BC,Buckley CV,Buckley JD,Opie T,Woods WG,Hammond GD,Bernstein ID

    更新日期:1994-08-01 00:00:00

  • Identifying mutant pathways in the histiocytoses.

    abstract::In this issue of Blood, the findings of Chakraborty et al and Emile et al support a model in which the mitogen-activated protein kinase (MAPK) and PI3K/AKT pathways are critical in the pathogenesis of 2 of the most common histiocytoses—Langerhans cell histiocytosis (LCH) and Erdheim-Chester disease (ECD)—whereas their...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-09-597765

    authors: Prince HM

    更新日期:2014-11-06 00:00:00

  • Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies.

    abstract::The mammalian target of rapamycin (mTOR) plays crucial roles in proliferative and antiapoptotic signaling in lymphoid malignancies. Rapamycin analogs, which are allosteric mTOR complex 1 (mTORC1) inhibitors, are active in mantle cell lymphoma and other lymphoid neoplasms, but responses are usually partial and short-li...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-04-346601

    authors: Gupta M,Hendrickson AE,Yun SS,Han JJ,Schneider PA,Koh BD,Stenson MJ,Wellik LE,Shing JC,Peterson KL,Flatten KS,Hess AD,Smith BD,Karp JE,Barr S,Witzig TE,Kaufmann SH

    更新日期:2012-01-12 00:00:00

  • A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo.

    abstract::We have developed a new helper-dependent (HD) adenoviral vector FTC that contains 3 cis-acting sequences as stuffer DNA: a human fragment of alphoid repeat DNA, matrix-attachment regions (MARs), and the hepatocyte control region enhancer. To determine the most robust human coagulation factor IX (hFIX) expression casse...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.11.3923

    authors: Ehrhardt A,Kay MA

    更新日期:2002-06-01 00:00:00

  • Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2.

    abstract::The antibody-mediated delivery of therapeutic agents to sites of angiogenesis is an attractive strategy for anticancer therapy, but is largely unexplored in hematologic malignancies. In the present study, we show that the extra domain B (EDB) of fibronectin, a marker of angiogenesis, is expressed in B-cell non-Hodgkin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-05-160747

    authors: Schliemann C,Palumbo A,Zuberbühler K,Villa A,Kaspar M,Trachsel E,Klapper W,Menssen HD,Neri D

    更新日期:2009-03-05 00:00:00

  • Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients.

    abstract::We infused six human immunodeficiency virus (HIV)-seropositive subjects with autologous CD8+ cytotoxic T cells (CTLs) enriched for HIV-specific cytotoxicity targeted against a diversity of HIV epitopes in gp120, gag p17 and p24, and nef. There was no toxicity and no subject deteriorated clinically. In the first 2 week...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Lieberman J,Skolnik PR,Parkerson GR 3rd,Fabry JA,Landry B,Bethel J,Kagan J

    更新日期:1997-09-15 00:00:00